MarketInOut Stock Screener Log In | Sign Up

CF PharmTech Inc H

HKSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
CF PharmTech Inc H stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeHKSE
Market Capitalization2,428.6 mln
Float183 mln
Earnings Date08/31/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

5.14
Highly suspicious

Relative Strength

23 / 100
Significantly lagging

Debt / Equity

0.09
Debt-free

Pre-Tax Margin

8%
Moderate margin

ROE

1.33
Very low

Business Description

CF PharmTech Inc. is a China-based company founded in 2007 that focuses on developing, manufacturing, and selling medicines for respiratory conditions. Its product range includes nasal sprays, inhalation solutions, nebulizers, and nasal cleaning devices targeting conditions such as allergic rhinitis, asthma, and chronic obstructive pulmonary disease. The company also offers contract development and manufacturing services to support other pharmaceutical businesses.

Key Fundamentals

EPS-0.02
ROE1.33
ROIC0.90
ROA1.02
Interest Cover14.92
EBITDA, mln30.25
EV / EBITDA91.38
EV / EBIT215
Revenue, mln145
EV / Revenue19.02

Quote Details

Last 5.30
Change -0.33 (-5.86%)
Open 5.76
Volume 1,004,200
Turnover 5,322,260
Average Volume 3,254,297

Financial Ratios

Pre-Tax Profit Margin8
Current Ratio2.08
Price / Book2.77
Price / Tangible Book3.20
Debt / Equity0.09
Price / Sales19.65

Financial Strength

Altman Z-Score5.3
Piotroski F-Score 4 / 9
Beneish M-Score5.14
Price to Graham Number5.68

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.36% 25 / 100   
1 Month -24.18% 12 / 100   
2 Months -66.37% 1 / 100   
6 Months -75.58% 2 / 100   
1 Year -82.08% 3 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog